NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Arix Bioscience

Arix Bioscience

Overview

Arix Bioscience is a global venture capital firm that invests in and builds breakthrough biotechnology companies focused on cutting-edge advances in life sciences.

Year Founded

2015

Portfolio Companies

9

Investments

Arix Bioscience investments
CompanyDateStageLead
EvommuneJun 2023Series BLead
EnsomaMay 2023Series B ExtensionCo-investor
EvommuneMar 2023Series BLead
EnsomaJan 2023Series BLead
Sorriso TherapeuticsDec 2021Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.